rs763307022
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000626.4(CD79B):c.323C>T(p.Thr108Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000626.4 missense
Scores
Clinical Significance
Conservation
Publications
- agammaglobulinemia 6, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- autosomal agammaglobulinemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CD79B | NM_000626.4 | c.323C>T | p.Thr108Ile | missense_variant | Exon 3 of 6 | ENST00000006750.8 | NP_000617.1 | |
| CD79B | NM_001039933.3 | c.326C>T | p.Thr109Ile | missense_variant | Exon 3 of 6 | NP_001035022.1 | ||
| CD79B | NM_001329050.2 | c.122-293C>T | intron_variant | Intron 2 of 4 | NP_001315979.1 | |||
| CD79B | NM_021602.4 | c.119-293C>T | intron_variant | Intron 2 of 4 | NP_067613.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CD79B | ENST00000006750.8 | c.323C>T | p.Thr108Ile | missense_variant | Exon 3 of 6 | 1 | NM_000626.4 | ENSP00000006750.4 | ||
| ENSG00000285947 | ENST00000647774.1 | c.50-293C>T | intron_variant | Intron 1 of 7 | ENSP00000497443.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251412 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461874Hom.: 0 Cov.: 34 AF XY: 0.0000358 AC XY: 26AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Agammaglobulinemia 6, autosomal recessive Uncertain:1
This sequence change replaces threonine with isoleucine at codon 108 of the CD79B protein (p.Thr108Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is present in population databases (rs763307022, ExAC 0.02%). This variant has not been reported in the literature in individuals with CD79B-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at